Cleared Traditional

K930578 - AT33 EMG

K930578 is an FDA 510(k) clearance for AT33 EMG, manufactured by Autoject Systems, Inc.. The device is a Class 2 Neurology device with product code HCC cleared through the Traditional 510(k) pathway after a 834-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1995
Decision
834d
Days
Class 2
Risk

K930578 is an FDA 510(k) clearance for the AT33 EMG. Classified as Device, Biofeedback (product code HCC), Class II - Special Controls.

Submitted by Autoject Systems, Inc. (Oak Dale, US). The FDA issued a Cleared decision on May 19, 1995 after a review of 834 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5050 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

FDA 510(k) Submission Details - K930578

510(k) Number K930578 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 04, 1993
Decision Date May 19, 1995
Days to Decision 834 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
685d slower than avg
Panel avg: 149d · This submission: 834d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HCC Device Classification - Class 2, Special Controls

Product Code HCC Device, Biofeedback
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HCC Device, Biofeedback

All 172
Devices cleared under the same product code (HCC) and FDA review panel - the closest regulatory comparables to K930578.
MUSCLESENSE ELECTROMYOGRAPHY DEVICE
K951350 · Smith and Nephew Donjoy, Inc. · Jun 1995
VERSATELL
K941959 · Progressive Concepts, Inc. · Jun 1995
MYOEXORCISER II FUAL
K951969 · Verimed Holdings, Inc. · Jun 1995
AT42
K930576 · Autoject Systems, Inc. · May 1995
AT64 SCR
K930577 · Autoject Systems, Inc. · May 1995
FOCUS EMG
K940050 · Fasstech · Feb 1995